CK-2127107
CK-2127107 Uses, Dosage, Side Effects, Food Interaction and all others data.
CK-2127107 is under investigation in clinical trial NCT03160898 (A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)).
| Trade Name | CK-2127107 |
| Generic | Reldesemtiv |
| Reldesemtiv Other Names | CK-2127107, Reldesemtiv |
| Type | |
| Formula | C19H18F2N6O |
| Weight | Average: 384.391 Monoisotopic: 384.15101555 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here CK-2127107
